8.03
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
|
|
37.25%
47.86
|
34.87 | 36.77 | 37.62 | 33.53 |
| Operating Income/Loss |
37.25%
-47.86
|
-34.87 | -36.77 | -37.62 | -33.53 |
| Nonoperating Income/Loss |
9.01%
4.08
|
4.484 | 3.201 | 3.066 | 3.148 |
| Income/Loss From Continuing Operations Before Tax |
44.08%
-43.78
|
-30.39 | -33.56 | -34.55 | -30.38 |
| Income/Loss From Continuing Operations After Tax |
44.08%
-43.78
|
-30.39 | -33.57 | -34.55 | -30.38 |
|
|
44.08%
-43.78
|
-30.39 | -33.57 | -34.55 | -30.38 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.08%
85.50
|
85.43 | 5.5494 | 57.26 | 56.28 |
| Diluted Average Shares |
0.08%
85.50
|
85.43 | 5.5494 | 57.26 | 56.28 |
| Basic Earnings Per Share |
41.67%
-0.51
|
-0.36 | -0.40 | -0.60 | -0.54 |
| Diluted Earnings Per Share |
41.67%
-0.51
|
-0.36 | -0.40 | -0.60 | -0.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):